drugset / Trial / NCT02983461

Use of Sildenafil for Treatment of Urinary Incontinence

NCT02983461

Phase 1 Active not recruiting 24 enrolled The University of Texas Medical Branch, Galveston
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators goal is to develop medical treatments for stress/mixed urinary incontinence. Sildenafil has been shown to improve blood flow as well as muscle mass and strength and to decrease muscle fatigue. The investigators believe that it will improve muscular atrophy in the pelvic floor, thus improving symptoms of urinary incontinence related to pelvic floor dysfunction.

Timeline

Start
2017-03-10
Primary completion
2020-03-01
Completion
2027-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 20 mg

Indications

No indication recorded.